ASCO 2016
MPNE at ASCO 2016
Monday, 6 June 2016
Metastatic Melanoma 2016- Georgina Long
Overall survival is continuously increasing in Melanoma, from 25- 35% in 1990 to above 70% at 1 year after diagnosis, both on immune therapy and targeted therapy.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment